Jupiter Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-125,506
Closed -$3.3M 577
2025
Q4
$3.3M Sell
125,506
-225,154
-64% -$4.91M 0.03% 299
2025
Q3
$5.99M Sell
350,660
-18,839
-5% -$270K 0.05% 252
2025
Q2
$4.64M Hold
369,499
0.04% 284
2025
Q1
$4.4M Hold
369,499
0.04% 287
2024
Q4
$5.41M Sell
369,499
-57,445
-13% -$803K 0.05% 274
2024
Q3
$5.36M Hold
426,944
0.05% 273
2024
Q2
$3.63M Hold
426,944
0.03% 288
2024
Q1
$4.49M Sell
426,944
-68,638
-14% -$762K 0.04% 261
2023
Q4
$5.15M Buy
495,582
+20,858
+4% +$166K 0.05% 253
2023
Q3
$3.01M Buy
474,724
+427,860
+913% +$3.16M 0.03% 295
2023
Q2
$404K Buy
+46,864
New +$420K ﹤0.01% 467

Other funds holding ZYME

Jupiter Asset Management's ZYME Position: Q1 2026 in Review

Jupiter Asset Management sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 125,506 shares — an estimated $3.3M sold.

Jupiter Asset Management first reported a position in ZYME in Q2 2023 and held it in 11 quarters. The position peaked at $5.99M in Q3 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Jupiter Asset Management reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Jupiter Asset Management sold 125,506 Zymeworks shares in Q1 2026, an estimated $3.3M.
  • Jupiter Asset Management first reported a position in Zymeworks in Q2 2023 and held it in 11 quarters.
  • Jupiter Asset Management's Zymeworks position peaked at $5.99M in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Jupiter Asset Management's 13F filing for Q1 2026, filed 12 May 2026.